Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and lo...
U.S. stock market update: Prenetics Global down 10.62%, despite securing $1 billion in financing and raising guidance, still struggles to prevent stock price decline
Roth MKM Reaffirms Their Buy Rating on Prenetics Group (PRE)
U.S. stock market midday update: Prenetics Global down 13.65%, received $1 billion investment but faced sell-off
PRE: Secured $1B non-dilutive capital to accelerate growth, targeting $1B+ ARR by 2029
Prenetics lifts 2026 IM8 revenue outlook to USD 210-220 million
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF) | PRE Stock News